Showing results (341-350 of 493) with videos related to

Sort By:
Pageof 50
Clinical and Experimental Immunology|September 10, 2009
A novel population of human CD56+ human leucocyte antigen D-related (HLA-DR+) colonic lamina propria cells is associated with inflammation in ulcerative colitisS C Ng, S Plamondon, H O Al-Hassi, et al.
Singapore Medical Journal|April 1, 1992
Abnormalities of chromosome 11Q in three cases of acute myeloid leukemiaS K Ten, M K Khor, H Khalid, et al.
Scandinavian Journal of Rheumatology|May 28, 2016
Lung and gastrointestinal complications are leading causes of death in SCORE, a multi-ethnic Singapore systemic sclerosis cohortA Santosa, C S Tan, G G Teng, et al.
JPGN Reports|November 17, 2025
In vitro radionuclide labeling characteristics of blenderized tube feeds for quantitative gastric motility assessmentBridget M Hron, Thomas S C Ng, Firouzeh Najafi Khosroshahi, et al.
Clinical Imaging|July 31, 2025
The role of PSMA PET/CT in distinguishing malignant from benign solitary bone lesions in prostate cancer patientsNadia Shah, Ashkan Eighaei Sedeh, Caitlin Deffler, et al.
Physical Review Letters|July 5, 2002
Spin-wave quantization in ferromagnetic nickel nanowiresZ K Wang, M H Kuok, S C Ng, et al.
Clinical Imaging|September 19, 2025
The role of PSMA PET/CT in identifying benign and malignant intracranial lesions in patients with prostate cancerCaitlin Deffler, Ashkan Eighaei Sedeh, Ellen Leitman, et al.
Journal of Graduate Medical Education|April 24, 2020
Parenting While in Training: A Comprehensive Needs Assessment of Residents and FellowsKirti Magudia, Thomas S C Ng, Alexander G Bick, et al.
Molecular Immunology|September 1, 1990
Heavy and light chain contributions to antigen binding in an anti-digoxin chain recombinant antibody produced by transfection of cloned anti-digoxin antibody genesR I Near, S C Ng, M Mudgett-Hunter, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 2, 2012
A randomized non-inferiority study comparing the addition of exenatide twice daily to sitagliptin or switching from sitagliptin to exenatide twice daily in patients with type 2 diabetes experiencing inadequate glycaemic control on metformin and sitagliptinR Violante, J H A Oliveira, K-H Yoon, et al.
Pageof 50